Evidence map›Paper›PMID 23576702›Full record

ArticleJournal of neurophysiology2013

Picrotoxin dramatically speeds the mammalian circadian clock independent of Cys-loop receptors.

G Mark Freeman, Masato Nakajima, Hiroki R Ueda, Erik D Herzog

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Astrocytic control of extracellular GABA drives circadian timekeeping in the suprachiasmatic nucleus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

G Mark FreemanDepartment of Biology, Washington University, Saint Louis, Missouri 63130, USA.
Masato Nakajima
Hiroki R Ueda
Erik D Herzog

Funding

CELLULAR BASIS OF CIRCADIAN RHYTHMS IN MAMMALSR01MH063104 · NIMH · WASHINGTON UNIVERSITY · PI HERZOG, ERIK · 2000 to 2013
$4.2M
Neural Circuit Analysis of a Mammalian Circadian PacemakerF30NS070376 · NINDS · WASHINGTON UNIVERSITY · PI FREEMAN, GEORGE MARK · 2010 to 2012
$84k
NIMH NIH HHS MH-63104NINDS NIH HHS F30-NS-070376
6 · The paper itself

Abstract

Picrotoxin is extensively and specifically used to inhibit GABAA receptors and other members of the Cys-loop receptor superfamily. We find that picrotoxin acts independently of known Cys-loop receptors to shorten the period of the circadian clock markedly by specifically advancing the accumulation of PERIOD2 protein. We show that this mechanism is surprisingly tetrodotoxin-insensitive, and the effect is larger than any known chemical or genetic manipulation. Notably, our results indicate that the circadian target of picrotoxin is common to a variety of human and rodent cell types but not Drosophila, thereby ruling out all conserved Cys-loop receptors and known regulators of mammalian PERIOD protein stability. Given that the circadian clock modulates significant aspects of cell physiology including synaptic plasticity, these results have immediate and broad experimental implications. Furthermore, our data point to the existence of an important and novel target within the mammalian circadian timing system.

Indexed as

AnimalsCell LineCircadian ClocksCysteine Loop Ligand-Gated Ion Channel ReceptorsDrosophilaGABA AntagonistsHumansIn Vitro TechniquesMicePeriod Circadian ProteinsPicrotoxinSuprachiasmatic NucleusCysteine Loop Ligand-Gated Ion Channel ReceptorsGABA AntagonistsPeriod Circadian ProteinsPicrotoxincircadianCys-loop receptorGABA receptorpicrotoxin

Identifiers

PMID23576702
PMCPMC3727043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.